Dividend Aristocrats in a Shaky Market: KO, PG, JNJ
In a dividend aristocrats shaky market, Coca-Cola, Procter & Gamble, Johnson & Johnson, McDonald's, and Colgate-Palmo...
Using Sentiment Indicators With Index Level Data
Using sentiment indicators with index level data combines psychology and price to strengthen analysis. This overview provides steps to integrate both streams.
26,603 articles
Mid-Cap Dividend ETF That's Been Quietly Beating SCHD
A little-known rival to SCHD has delivered competitive long-run gains and steady monthly income, thanks to a mid-cap ...
Prices Surge Amid Iran Tensions as Oil Markets Rally
Oil prices surged as tensions with Iran intensified, signaling higher pump costs for consumers. Analysts warn househo...
VFIAX Still Beats Buy-And-Hold for 2026 Investors
As market conditions shift in 2026, VFIAX remains a top pick for buy-and-hold strategies. The fund combines a low 0.0...
I Have Zero Envy: Why a 75-Year-Old Chooses Work Today
A 75-year-old who still works and lives frugally illustrates how a simple philosophy can guide steady investing amid ...
SCHD’s $71.6 Billion Portfolio Delivers 20% YTD Gain
Schd’s $71.6 billion portfolio has posted a 20% year-to-date price gain alongside a 3.3% yield, underscoring the appe...
Stock Market Today, March: Oil Drops Lift Airlines
In March, oil price declines helped airline stocks rally even as the broader market parsed mixed signals. This articl...
Live Nasdaq Composite Falls as Markets React to Middle East
Investors paused on news from Middle East diplomacy talks, pushing the Nasdaq Composite lower as rates and energy mar...
Pro-Crypto Kevin Warsh Trump Set to Lead the Fed Today
Kevin Warsh is sworn in as Fed chair with a crypto-forward stance, a development traders say could redefine policy an...
Dips Below Barrel Despite Tension: Is Oil Stock Worth It?
Oil prices have slipped below $70 even as shipping tensions threaten the Strait of Hormuz. This guide explains what d...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Crashing XRP: Here's How It Could Get Back Over $2 This Year
XRP has fallen from recent highs, but a rebound back above $2 is on the table if key catalysts align. This guide brea...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status